Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01515072 · ClinicalTrials.gov registry record · NA
Remote Ischemic Preconditioning in Neurological Death Organ Donors
A NA study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 321
- Enrollment target
NCT01515072 is a NA study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 321 participants.
The verdict
NCT01515072, a NA study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 321 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether application of lower limb remote ischemic preconditioning (RIPC) after determination of brain death improves donor stability, organ quality, organ yield, and early post transplant clinical outcomes. Neurological death donors will be stratified into standard and extended criteria donors (SCD/ECD) and randomized in a 1:1 fashion to RIPC or No intervention. The primary outcome is the number of organs recovered per donor. Secondary outcomes include donor hemodynamic state, donor organ-specific function parameters, pulsatile perfusion parameters, number of organs transplanted per donor, recipient hospital free survival and delayed graft function of kidneys. The sample size is powered to detect a difference of 0.44 organs recovered.
Interventions
- OTHER RIPC (Remote Ischemic Preconditioning)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 321 participants |
| Start Date | 2011-07 |
| Est. Completion | 2015-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01515072
The ClinicalTrials.gov registry entry for NCT01515072 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 321 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RIPC (Remote Ischemic Preconditioning) is the first listed.
NCT01515072 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01515072 about?
NCT01515072 is a clinical study titled "Remote Ischemic Preconditioning in Neurological Death Organ Donors". The purpose of this study is to determine whether application of lower limb remote ischemic preconditioning (RIPC) after determination of brain death improves donor stability, organ quality, organ yield, and early post transplant clinical outcomes. Neurological death donors will be stratified into ...
What is the current status of trial NCT01515072?
This trial is currently completed. It is a NA study. The enrollment target is 321 participants. The study started on 2011-07. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01515072?
The interventions under investigation include: RIPC (Remote Ischemic Preconditioning) (OTHER).
Who is sponsoring clinical trial NCT01515072?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.